Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.

Anas M SaadMuneer J Al-HusseiniAhmed ElgebalyOmar A AboshadySami SalahiaOmar Abdel-Rahman

Published in: Expert review of gastroenterology & hepatology (2018)

Prior malignancy does not adversely impact survival of stage IV esophageal cancer. These results should be taken into consideration when designing clinical trials.

Keyphrases

clinical trial
type diabetes
randomized controlled trial
free survival
study protocol